IP Library Granted Patent US 11,505,389
Granted Patent B2
US 11,505,389 · App. 17/145,483 · Granted Nov 22, 2022

Separating layer for the transport of pharmaceutical secondary packagings

Inventors: Patrick Wolf (St. Gallen, CH); Elisa Wiesner (Ludesch, AT); Arne Kloke (St. Gallen, CH)
Assignee: SCHOTT SCHWEIZ AG
B65D77/26A61J1/16B65D77/06B65D77/2024
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,505,389
App. No.
17/145,483
Granted
Nov 22, 2022
Kind
B2
Abstract

A separating layer for the transport of pharmaceutical secondary packagings and to a transport system for transporting pharmaceutical secondary packagings which comprises the separating layer are provided. The separating layer is a polymer layer having a planar section extending in an axial direction along a longitudinal axis and an elevation extending normal to the longitudinal axis. The separating layer has in the axial direction a normal spring force that is 0.2 to 5 N.

Claims (29)

1. A transport system for transporting pharmaceutical secondary packagings, comprising:

a transport box;

a separating layer; and

two pharmaceutical secondary packagings in the transport box and separated by the separating layer,

wherein the separating layer comprises a polymer layer having a planar section extending in an axial direction along a longitudinal axis and an elevation extending normal to the longitudinal axis, the separating layer having in the axial direction a normal spring force that is 0.2 to 5 N.

2. The transport system of claim 1 , wherein the separating layer further comprises a second planar section, the elevation being arranged between the planar section and the second planar section.

3. The transport system of claim 2 , wherein the separating layer is arranged such that the planar section and the second planar section are in contact with bottom faces of the two pharmaceutical secondary packagings, respectively, with the elevation projecting between the two pharmaceutical secondary packagings so that the two pharmaceutical secondary packagings are not in contact with one another.

4. The transport system of claim 1 , wherein the planar section contacts a bottom face of a first of the two pharmaceutical secondary packagings and contacts a top face of a second of the two pharmaceutical secondary packagings.

5. The transport system of claim 1 , wherein in the axial direction the normal spring force is 0.5 to 2 N.

6. The transport system of claim 1 , wherein the separating layer has in the axial direction an axial spring force that is 1 to 50 N.

7. The transport system of claim 6 , wherein in the axial direction the axial spring force is 20 to 30 N.

8. The transport system of claim 1 , wherein the two pharmaceutical secondary packagings are trough-shaped with an edge along a top face which extends along a plane of the top face.

9. The transport system of claim 1 , wherein the two pharmaceutical secondary packagings are sealed on a top face by a removable protective film.

10. The transport system of claim 9 , wherein the removable protective film comprises a material selected from a group consisting of polyethylene and/or permeable ultrafine fibre nonwoven fibers made of polyethylene.

11. The transport system of claim 1 , wherein the two pharmaceutical secondary packagings are each shealthed in a sealed bag.

12. The transport system of claim 1 , wherein the two pharmaceutical secondary packagings have a sterile interior.

13. The transport system of claim 1 , wherein the transport box is made of the polymer of the separating layer.

14. The transport system of claim 1 , wherein the separating layer has a width and the transport box has an internal width and the transport system further comprises a ratio of the width to the internal width of 0.8 to 1.5.

15. The transport system of claim 14 , wherein the separating layer has a length and the transport box has an internal length and the transport system further comprises a ratio of the length to the internal length of 1.1 to 2.0.

16. The transport system of claim 1 , wherein the separating layer has a length and the transport box has an internal length and the transport system further comprises a ratio of the length to the internal length of 1.1 to 2.0.

17. The transport system of claim 1 , wherein the two pharmaceutical secondary packagings comprise each 10 to 200 pharmaceutical primary packagings.

18. The transport system of claim 17 , wherein transport system, in an impact test according to the Incline Impact Test ASTM D880-92 (2015) with an impact speed of 2.14 m/s, exhibits damage to not more than 50% of the pharmaceutical primary packagings.

19. The transport system of claim 17 , wherein transport system, after running a transport simulation program according to ASTM D4169-16, DC12, not including program I, safety level I, there are 6000 or less particles having a size of 15 μm to 25 μm on an outside or an inside of the pharmaceutical primary packagings.

20. A transport system for transporting pharmaceutical secondary packagings, comprising:

a transport box;

a separating layer; and

two pharmaceutical secondary packagings in the transport box and separated by the separating layer,

wherein the two pharmaceutical secondary packagings comprise each 10 to 200 pharmaceutical primary packagings,

wherein the transport system, after running a transport simulation program according to ASTM D4169-16, DC12, not including program I, safety level I, there are 6000 or less particles having a size of 15 μm to 25 μm on an outside or an inside of the pharmaceutical primary packagings.

Assignments (2)
CHANGE OF NAME Recorded Nov 7, 2022
From: SCHOTT SCHWEIZ AG
To: SCHOTT PHARMA SCHWEIZ AG
Reel/Frame 061895/0026 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2021
From: WIESNER, ELISA; WOLF, PATRICK, DR.; KLOKE, ARNE, DR.
To: SCHOTT SCHWEIZ AG
Reel/Frame 055559/0619 →
Priority Claims (3)
EP 20151303 · Jan 10, 2020 · regional
EP 20151443 · Jan 13, 2020 · regional
EP 20189762 · Aug 6, 2020 · regional
Continuity (1)
Related Publication 20210214142A1 · Jul 15, 2021